A guidance document developed by the CDC for laboratories performing lymphocyte immunophenotyping assays in HIV-infected persons. The recommendations cover laboratory safety, specimen handling, flow cytometer quality control, and data analysis. The document reflects current technology in a rapidly changing field.
Use Cases
- Standardizing laboratory safety protocols based on CDC recommendations for handling HIV specimens.
- Developing quality assurance procedures for flow cytometry based on the described quality control guidelines.
- Informing data analysis and reporting standards for CD4+ T-cell determination results.
Strengths
- Document is developed by the CDC, a recognized public health authority.
- Recommendations cover a wide scope from specimen collection to data reporting.
Limitations
- Row count is unknown, which may limit suitability assessment.
- Column-level documentation is absent; field semantics must be inferred after download.
- Last update date is unknown; freshness unverified.
Provenance
- Source
- Centers for Disease Control and Prevention (CDC)
- Collection Method
- Developed as formal guidance.